ALBO

Albireo Pharma, Inc. Common Stock
ALBO

Overview Fund Activity
Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

42 hedge funds and large institutions have $32.9M invested in Albireo Pharma, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 11 closing their positions.

Holders
42
Holders Change
–
Holders Change %
0%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
13
Reduced
7
Closed
11
Calls
$2.84M
Puts
$1.05M
Net Calls
+$1.79M
Net Calls Change
+$1.49M

Top Buyers

1
GPP
1
Great Point Partners
Connecticut
$4.2M
2
NI
2
Numeric Investors
Massachusetts
$2.02M
3
BC
3
Broadfin Capital
New York
$3.15M
4
AWMDMG
4
Austin W. Marxe & David M. Greenhouse
New York
$4.99M
5
FNYS
5
First New York Securities
New York
$772K

Top Sellers

1
O
1
OrbiMed
New York
$2.83M
2
UOC
2
UBS O'Connor
Illinois
$0
3
EI
3
EAM Investors
California
$0
4
BBA
4
Baker Bros. Advisors
New York
$0
5
VM
5
VHCP Management
New York
$4.04M
Name Market Value Shares Shares
Change 		Shares
Change %
Manulife (Manufacturers Life Insurance)
51
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– – -269 Closed
Barclays
52
Barclays
United Kingdom
– – -87 Closed
SM
53
Sabby Management
Florida
– – – –
VKH
54
Virtu KCG Holdings
New York
– – – –
Deutsche Bank
55
Deutsche Bank
Germany
$0 14 +14 New
1 2
3